As most tumors respond readily to dopamine agonists in terms of reductions in prolactin levels and decreased volume, radiotherapy should now rarely be used in the treatment of prolactinoma.

independent of tumor size or drug resistance or intolerance,” declare Masami Ono and Nobuhiro Miki, two of the investigators involved in this prospective study. Prolactinoma is the underlying ...